Latigo Biotherapeutics, Inc. (LTGO)

NASDAQ: LTGO · Real-Time Price · USD

20.06

+0.68 (3.51%)

At close: Aug 13, 2026, 4:00 PM EDT

20.01

-0.05 (-0.25%)

After-hours: Aug 13, 2026, 7:34 PM EDT

Latigo Biotherapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-112.32	-110.39	-63.45
Net Income	-111.18	-109.17	-61.18
Earnings Per Share	-19.74	-20.12	-14.02
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	42.18	69.44	17.92
Total Debt	0.55	0.69	0.85
Net Cash (Debt)	41.62	68.75	17.07
Net Cash Growth	-	302.81%	-
Net Cash Per Share	7.39	12.67	3.91

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-103.47	-97.56	-50.96
Capital Expenditures	-0.03	-0.14	-0.07
Free Cash Flow	-103.5	-97.69	-51.03
Free Cash Flow Growth	-	-	-